Investor Niklason Laura E
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Niklason Laura E . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-20 13D/A HUMA / Humacyte, Inc. 7,705,473 6,007,745
2024-09-03 13D/A HUMA / Humacyte, Inc. 9,186,901 7,705,473
2024-06-04 13D/A HUMA / Humacyte, Inc. 10,153,195 9,186,901
2024-03-08 13D/A HUMA / Humacyte, Inc. 10,050,822 10,153,195
2023-09-15 13D/A HUMA / Humacyte, Inc. 11,612,809 10,050,822
2023-08-22 13D/A HUMA / Humacyte, Inc. 13,911,388 11,612,809
2023-06-15 13D/A HUMA / Humacyte, Inc. 18,786,211 13,911,388
2023-05-26 13D/A HUMA / Humacyte, Inc. 22,336,411 18,786,211
2022-09-19 13D/A HUMA / Humacyte, Inc. 23,268,279 22,336,411
2021-08-30 13D HUMA / Humacyte, Inc. 23,268,279 23,268,279